Your money or their life. Drug to combat blood pressure may come at a price, but the wider health benefits should not be underestimated, says Nick Summerton.
New anti-hypertensive drugs, although more expensive than conventional treatments, have significant benefits in the management of cardiovascular disease. NICE analysis of cost-benefits don't consider their impact on other risk factors for cardiovascular disease, such as diabetes. A broader perspective is necessary when assessing the public health of anti-hypertensive drugs.